Prospective Study of Undiagnosed Celiac Disease

Mayo Clinic

Status: Completed

Conditions: Celiac Disease

Treatments: Other: Dietary instruction

Study type: Interventional

Funder types: Other

Identifiers

NCT01317914

10-000178

Details and patient eligibility

About

Direct benefits to the participants, who are diagnosed with celiac disease may be substantial and could include lessening or prevention of GI symptoms, correction of biochemical abnormalities and reduction in risk for malignancies or bone disease which are most common in untreated celiac disease. However, the precise benefit is unknown and the motivation for this proposed study. If these individuals have a positive celiac serology test at the present time there is a high likelihood that they may have celiac disease.

Enrollment: 31 patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• At least 60 years old
• Male and female

Retrospective testing for celiac disease was done on previously stored serum. Contacting specific individuals for inclusion into study

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

31 participants in 1 patient group

Dietary instruction on Gluten Free Diet

Experimental group

Treatment:

Other: Dietary instruction